Close

Forest Labs (FRX) Submits NDA to FDA to FDC of Nebivolol and Valsartan

February 27, 2014 8:01 AM EST Send to a Friend
Forest Laboratories, Inc. (NYSE: FRX) announced that it has submitted a New Drug Application (NDA) to the Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login